20028 ⎘
Medicinal preparations characterised by special physical form; Galenical forms characterised by the site of application; Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception
LONG ACTING DRUG DELIVERY DEVICE AND ITS USE IN CONTRACEPTION
#2ELASTIC SHEET WITH FUNCTION OF RE-ACTIVATING ENDOMETRIAL BASAL LAYER IN UTERINE CAVITY AND FORMING METHOD THEREOF
#3DEGRADABLE INTRAUTERINE SYSTEM FOR THE PROLONGED RELEASE OF AN ACTIVE INGREDIENT IN THE UTERINE CAVITY
#4INTRAUTERINE DEVICE WITH RETRIEVAL THREAD
#5AMMONIA OXIDIZING MICROORGANISMS FOR USE AND DELIVERY TO THE UROGENITAL SYSTEM
#6INTRAUTERINE SYSTEMS COMPRISING ANTI-INFECTIVES FOR STEADY-STATE ACCUMULATION TO DISTAL EXTRAUTERINE TISSUE
#7SYSTEM FOR RELEASING A HAEMOSTATIC AGENT INTO THE UTERINE CAVITY
#8AMMONIA OXIDIZING MICROORGANISMS FOR USE AND DELIVERY TO THE UROGENITAL SYSTEM
#9METHOD AND DEVICE FOR PROVIDING EFFECTIVE CONTRACEPTION
#10METHOD AND DEVICE FOR PROVIDING EFFECTIVE CONTRACEPTION
#11AMMONIA OXIDIZING MICROORGANISMS FOR USE AND DELIVERY TO THE UROGENITAL SYSTEM
#12Intrauterine device with retrieval thread
#13DRUG DELIVERY SYSTEM COMPRISING A NON-STEROIDAL ANTI-INFLAMMATORY (NSAID) AND A PROGESTOGENIC COMPOUND AND METHODS FOR MANUFACTURING
#14AMMONIA OXIDIZING MICROORGANISMS FOR USE AND DELIVERY TO THE UROGENITAL SYSTEM
#15AMMONIA OXIDIZING MICROORGANISMS FOR USE AND DELIVERY TO THE UROGENITAL SYSTEM
#16Refillable Implantable Device for Delivering a Drug Compound
#17TREATMENT OF PAIN AND/OR PAIN RELATED SYMPTOMS ASSOCIATED WITH DYSMENORRHEA
#18METHODS, COMPOSITIONS AND DEVICES FOR TREATING NEUROINFLAMMATORY CONDITIONS
#19Intrauterine device with retrieval thread
#20Treatment of endometriosis by intravaginal administration of a low dose of a selective progesterone receptor modulator (SPRM), anti-progestin, or anti-progestational agent
#21AGENTS AND METHODS FOR MODULATING PATHOGEN ACTIVITY
#22Long acting drug delivery device and its use in contraception
#23Treating gynecological malignancies with deployable implants
#24Treatment of pain and/or pain related symptoms associated with dysmenorrhea
#25Method for reducing the incidence and prevalence of human papilloma virus (HPV) and for providing protection against sexually transmitted infections
#26AMMONIA OXIDIZING MICROORGANISMS FOR USE AND DELIVERY TO THE UROGENITAL SYSTEM
#27METHOD FOR TREATMENT OF INFERTILITY, PHARMACEUTICAL COMPOSITION FOR TREATMENT OF INFERTILITY AND METHOD FOR PRODUCING THE SAME
#28Intrauterine device with retrieval thread
#29ELASTIC SHEET WITH FUNCTION OF RE-ACTIVATING ENDOMETRIAL BASAL LAYER IN UTERINE CAVITY AND FORMING METHOD THEREOF
#30TREATMENT OF UTERINE FIBROIDS BY INTRAVAGINAL ADMINISTRATION OF A LOW DOSE OF SELECTIVE PROGESTERONE RECEPTOR MODULATOR (SPRM), ANTI-PROGESTIN, OR ANTI-PROGESTATIONAL AGENT
#31Treatment of endometriosis by intravaginal administration of a low dose of a selective progesterone receptor modulator (SPRM), anti-progestin, or anti-progestational agent
#32Implantable medicament delivery system
#33Vaginal ring removal device and methods
#34COPPER INTRAUTERINE DEVICE
#35Use of N-acetyl-5-methoxytryptamine or analogues thereof, for promoting the mechanism of implantation of the embryo and related compositions and culture media
#36COMPOSITIONS AND METHODS FOR INHIBITING AUTOPHAGY AND CONTRACEPTION
#37Intrauterine delivery system for contraception
#38IMPROVED CONTRACEPTIVE METHODS AND COMPOSITIONS AND DEVICES FOR USE THEREIN
#39Long acting drug delivery device and its use in contraception
#40DRUG DELIVERY SYSTEM COMPRISING A NON-STEROIDAL ANTI-INFLAMMATORY (NSAID) AND A PROGESTOGENIC COMPOUND AND METHODS FOR MANUFACTURING
#41INTRAVAGINAL DRUG DELIVERY DEVICE
#42METHOD OF CONTRACEPTION
#43Intrauterine device, and a method of reducing the rate of diffusion of active ingredients in said intrauterine device
#44Intrauterine device with retrieval thread
#45SURFACE TOPOGRAPHIES FOR NON-TOXIC BIOADHESION CONTROL
#46Ulipristal acetate for prevention and treatment of breast tumors
#47Cervicouterine device that increases protection against the risk of contracting cervicouterine cancer
#48INTRAUTERINE DELIVERY SYSTEM
#49System for delivery of medication in treatment of disorders of the pelvis
#50Intrauterine device and method for reducing the rate of diffusion of active ingredients in said device by adding inert particulates to a polymeric coating
#51COPPER INTRAUTERINE DEVICE
#52Use of N-acetyl-5-methoxytryptamine or analogues thereof, for promoting the mechanism of implantation of the embryo and related compositions and culture media
#53INTRAUTERINE APPLICATION OF 18-METHYL-15SS,16SS-METHYLENE-19-NOR-20-SPIROX-4-EN-3-ONE SYSTEMS, INTRAUTERINE SYSTEMS CONTAINING 18-METHYL-15SS,16SS-METHYLENE-19-NOR-20-SPIROX-4-EN-3-ONE, AS WELL AS THE USE THEREOF IN CONTRACEPTION AND GYNAECOLOGICAL THERAPY
#54Drug delivery system
#55Implantable delivery device system for delivery of a medicament to a bladder
#56Intrauterine delivery system for contraception
#57DRUG DELIVERY SYSTEM
#58Treatment of endometriosis by intravaginal administration of a low dose of a selective progesterone receptor modulator (SPRM), anti-progestin, or anti-progestational agent
#59Methods and apparatus for inserting a device or pharmaceutical into a body cavity
#60INTRAUTERINE ELECTRONIC CAPSULE FOR ADMINISTERING A SUBSTANCE
#61INTRAUTERINE DEPOSIT
#62Intrauterine system
#63Apparatus and methods of treatment of pathologic proliferative conditions uterine tissue
#64Time-selective bioresorbable or collapsible drug delivery systems and methods
#65Process and intra-cervical device for the local release of drugs in the local-regional treatment of cervical cancer
#66Silver ion delivery platform
#67INTRAUTERINE DELIVERY SYSTEM FOR CONTRACEPTION
#68MEDICAL DEVICES FOR TREATING UROLOGICAL AND UTERINE CONDITIONS
#69Use of a hydrophilic matrix comprising a polyacrylic acid derivative, a cellulose ether and a disintegrant in the manufacture of a medicament for treating female genital disorders
#70Intrauterine deposit
#71Intrauterine system
#72Medicament delivery device and a method of medicament delivery
#73Drug delivery system
#74Delivery system
#75Chemoprevention of endometrial cancer
#76Use of bioabsorbable, biocompatible adhesives as a method of female contraception
#77Medicament delivery device and a method of medicament delivery
#78Fp receptor antagonists or pgf2 alpha antagonists for treating pathological conditions of the uterus
#79Methods and systems for coating particles
#80Medical devices for treating urological and uterine conditions
#81Fp receptor antagonists or pgf2 alpha antagonists for treating menorrhagia